Regeneron Pharmaceuticals Inc (REGN)

Debt-to-capital ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	1,984,400	1,982,900	1,981,400	1,980,000	1,978,500
Total stockholders’ equity	US$ in thousands	29,353,600	25,973,100	22,664,000	18,768,800	11,025,300
Debt-to-capital ratio		0.06	0.07	0.08	0.10	0.15

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,984,400K ÷ ($1,984,400K + $29,353,600K)
= 0.06

The debt-to-capital ratio of Regeneron Pharmaceuticals Inc has shown a consistent downward trend over the past five years, decreasing from 0.15 as of December 31, 2020, to 0.06 as of December 31, 2024. This indicates that the company has been effectively reducing its reliance on debt in relation to its total capital structure. A lower debt-to-capital ratio suggests a healthier financial position and lower financial risk, as the company is using less debt to finance its operations compared to its equity. Overall, this trend reflects positively on the company's financial strength and stability.